Results 281 to 290 of about 2,034,935 (392)

Management Challenges of Refractory Immune Thrombocytopenia during Pregnancy: A Case Report

R Akshaya, Aboobacker Mohamed Rafi, Deepak Charles   +2 more
openalex   +1 more source

Amustaline/glutathione pathogen‐reduced red cell hemoglobin utilization in complex cardiac surgery: A post hoc analysis of the phase 3 ReCePI trial

Transfusion, EarlyView.
Abstract Background The ReCePI randomized, controlled trial compared amustaline/glutathione pathogen‐reduced (PR) and conventional red blood cell (RBC) transfusions in cardiac surgery. Study design and methods We performed a post‐hoc analysis of hemoglobin (Hb) utilization and safety outcomes.
Ian J. Welsby, Michael E. Sekela, Edward L. Snyder, James D. Gorham, John S. McNeil, Kathy Liu, Stanley Bentow, Thomas Gniadek, Laurence Corash, Nina Mufti, Richard J. Benjamin, for the ReCePI Study Group   +11 more
wiley   +1 more source

Influence of Anxiety Level and Degree of Alexithymia on Quality of Life in Adult Patients With Primary Immune Thrombocytopenia. [PDF]

Actas Esp Psiquiatr
Liang S, Wu T, Chai L, Ai T, Lu S.
europepmc   +1 more source

Genetic Associations and Platelet Count Trajectories in Gestational Thrombocytopenia and Immune Thrombocytopenia during Pregnancy [PDF]

Kexin Shen, Chen Zhao, Lulu Wang, Mengtong Zang, Peng Zhao, Zhuo‐Yu An, Xiaolu Zhu, Qiu-Sha Huang, Haixia Fu, Xiao‐Jun Huang, Xiao Hui Zhang   +10 more
openalex   +1 more source

Rare complication of treated immune thrombocytopenia [PDF]

, 2017
Radhika Gangaraju, Anton Rets, Kristi J. Smock, Nahla Heikal   +3 more
openalex   +1 more source

Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services

Transfusion, EarlyView.
Abstract Background Platelet transfusion refractoriness (PTR) is a clinically important condition. The Human Leukocyte Antigen and Human Platelet Antigen (HLA/HPA) Platelet Program at Canadian Blood Services (CBS) provides platelet products to support such patients.
Natasha Rickards, Phuoc‐An Duong Hoang, Johnathan Mack, Matthew Seftel, John T. Blake, Akash Gupta   +5 more
wiley   +1 more source

Predictors of response to emergent therapies in paediatric immune thrombocytopenia. [PDF]

Br J Haematol
O'Farrell C, Luckie TM, Willis MJ, Kirk SE, Lucari BR, Scheurer ME, Gao X, Grimes AB.   +7 more
europepmc   +1 more source

Safety and efficacy of combined heparin/citrate anticoagulation for cell therapy collections in healthy adult allogeneic donors

Transfusion, EarlyView.
Abstract Background Reports on the safety and efficacy of combination heparin and citrate anticoagulation with cell therapy collections in adults are limited. There are no reports on the use of this combination in healthy allogeneic adult donors undergoing cell therapy collection. This retrospective analysis is the first study to examine its safety and
Jiahao Zhang, Minlin Wu, Sabrina Racine‐Brzostek, Sarah Shayo, Karina Yazdanbakhsh, Stephanie Dormesy, Patricia A. Shi   +6 more
wiley   +1 more source

Mechanistic insights into PD-1 inhibitor-associated immune thrombocytopenia: a case report integrating longitudinal transcriptomic profiling. [PDF]

J Immunother Cancer
Li H, Wang Y, Zhu J, Chen H, Liu T, Ai L.   +5 more
europepmc   +1 more source

The long-term efficacy of eltrombopag in children with immune thrombocytopenia [PDF]

Yang Li, Bao-Hua Sang, Chunhui Yang, Zu-Gang Xiao, Chun-Lian Fang, Yu Lv, Na Li, Qing Yang, Shu-Min Chai, Xin Tian, Xianwen Zhang, Ti‐Long Huang   +11 more
openalex   +1 more source